HARROW, INC. — Director's Dealing 2013

Mar 16, 2013

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2012-12-31

Reporting Person: DERMASTAR INTERNATIONAL, LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-02-28	Common Stock	C	1454962	—	Acquired	0	Direct
2012-04-30	Common Stock	J	193047	$762534	Acquired	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-01-01	Convertible Debenture	$0.6668	P	856087	Acquired	2012-04-05	Common Stock (1454962)	Direct
2012-02-28	Convertible Debenture	$0.6668	C	856087	Disposed	2012-04-05	Common Stock (1454962)	Direct
2012-04-30	Warrants	$5.925	P	48262	Acquired	2015-04-29	Common Stock (48262)	Direct

Footnotes

F1: As previously reported on a Form 4 filed on July 20, 2012, on July 12, 2012, the reporting person distributed to its members all securities of the Issuer held by it and was subsequently dissolved.

F2: Represents the shares of common stock acquired by the reporting person upon automatic conversion of a convertible debenture issued by the Issuer on April 5, 2010 and acquired from the initial holder by the reporting person in a private transaction on January 1, 2012.

F3: Represents shares received upon the exchange of amounts owing under an outstanding Line of Credit into common stock of the Issuer.